Fe-doped mesoporous silica catalyzes ascorbic acid oxidation for tumor-specific therapy in scaffold
- 1 May 2023
- journal article
- research article
- Published by Elsevier BV in Colloids and Surfaces B: Biointerfaces
- Vol. 225, 113251
- https://doi.org/10.1016/j.colsurfb.2023.113251
Abstract
No abstract availableFunding Information
- National Natural Science Foundation of China
This publication has 51 references indexed in Scilit:
- O 2 ⋅− and H 2 O 2 -Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological AscorbateCancer Cell, 2017
- Copper-doped mesoporous silica nanospheres, a promising immunomodulatory agent for inducing osteogenesisActa Biomaterialia, 2016
- Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDHScience, 2015
- Manganoporphyrins Increase Ascorbate-Induced Cytotoxicity by Enhancing H2O2 GenerationCancer Research, 2013
- Influence of ascorbic acid on the activity of the investigational anticancer drug KP1019JBIC Journal of Biological Inorganic Chemistry, 2011
- Mechanisms of Ascorbate-Induced Cytotoxicity in Pancreatic CancerClinical Cancer Research, 2010
- Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in miceProceedings of the National Academy of Sciences of the United States of America, 2008
- Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivoProceedings of the National Academy of Sciences of the United States of America, 2007
- Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a pro-drug to deliver hydrogen peroxide to tissuesProceedings of the National Academy of Sciences of the United States of America, 2005
- In the absence of catalytic metals ascorbate does not autoxidize at pH 7: ascorbate as a test for catalytic metalsJournal of Biochemical and Biophysical Methods, 1988